Data updated: Mar 29, 2026

EMCURE PHARMA

Pharmaceuticals

Pharma

EMCURE PHARMA is a pharmaceutical company with 6 FDA-approved products.

-

Since

6

Drugs

-

Trials

29

Approved (2yr)

Key Drugs

LAMIVUDINE; ZIDOVUDINE

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

ATAZANAVIR SULFATE 2025-08-12

ATAZANAVIR SULFATE 2025-08-12

ATAZANAVIR SULFATE 2025-08-12

ATAZANAVIR SULFATE 2025-07-23

ATAZANAVIR SULFATE 2025-07-17

NEVIRAPINE 2025-07-01

ATAZANAVIR SULFATE 2025-06-26

ATAZANAVIR SULFATE 2025-05-08

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...